Join
Live feed
·
INSIDERFilingvia Quantisnow
Edgewise Therapeutics Inc. logo

Chief Business Officer Derakhshan Behrad converted options into 5,781 shares and sold $33,360 worth of shares (2,491 units at $13.39), increasing direct ownership by 16% to 23,645 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EWTX (Edgewise Therapeutics Inc.) and more on Quantisnow.